4//SEC Filing
TRAVERSA SERGIO 4
Accession 0001213900-23-097032
CIK 0001553643other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:28 PM ET
Size
5.5 KB
Accession
0001213900-23-097032
Insider Transaction Report
Form 4
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-12-15+183,881→ 183,881 totalExercise: $2.48From: 2024-03-15Exp: 2033-12-15→ Common Stock (183,881 underlying)
Footnotes (1)
- [F1]The options vest in 16 equal quarterly installments commencing on March 15, 2024.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001565832
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:28 PM ET
- Size
- 5.5 KB